Australia's Zelira climbs as firm expands into Germany via distribution deal

Zelira Therapeutics

20/09/2021 02:46

** Shares of Zelira Therapeutics Ltd  ZLD.AX  rise as much
as 10.8% to A$0.041, posting their biggest intraday pct gain
since June 3
    ** Biopharma co enters five-year distribution deal with
Canada-based IM Cannabis Corp's  IMCC.CD  unit Adjupharm to
market Zenivol in Germany  urn:newsml:reuters.com:*:nASX1Yy5pz
    ** Zenivol is a cannabinoid-based medicine for the treatment
of chronic insomnia
    ** ZLD shares hit their highest since Aug. 19
    ** Trading volume of 3.1 mln shares nearly thrice the 30-day
avg volume of 1.1 mln
    ** Stock down 59.8% this year, as of last close

 (Reporting by Yamini C S)
 ((Yamini.CS@thomsonreuters.com;))